目的 探討COPD 患者急性加重期和穩(wěn)定期血漿IL-13 與白三烯B4 ( LTB4 ) 水平的變化。方法 收集符合納入標(biāo)準(zhǔn)的COPD 患者30 例, 以健康志愿者30 例作為對照。比較COPD 患者急性加重期、穩(wěn)定期血漿IL-13 與LTB4 水平, 并與正常對照組比較, 對IL-13 與LTB4 進(jìn)行相關(guān)分析。結(jié)果 COPD 急性加重期患者血漿IL-13 與LTB4 水平分別為( 31. 13 ±4. . 59) pg/mL 和( 339. 52 ±45. 50) pg/mL, 在穩(wěn)定期分別為( 20. 72 ±4. 39) pg/mL 和( 196. 71 ±53. 85) pg/mL, 均較正常對照組顯著增高[ ( 6.04 ±1. 58) pg/mL 和( 63. 36 ±11. 82) pg/mL, P 均 lt; 0. 05] , 急性加重期IL-13 與LTB4水平顯著高于穩(wěn)定期( P 均 lt;0. 05) 。急性加重期和穩(wěn)定期血漿IL-13 水平與LTB4 水平均呈明顯正相關(guān)( r =0. 985, r =0. 970; P = 0. 000) 。結(jié)論 IL-13 和LTB4 可以作為反映COPD 病情的免疫學(xué)指標(biāo), 可通過監(jiān)測IL-13 和LTB4 水平來反映病情變化及指導(dǎo)治療。
引用本文： 于潁佳,許西琳. COPD患者血漿白細(xì)胞介素-13與白三烯B4水平變化的研究. 中國呼吸與危重監(jiān)護(hù)雜志, 2009, 09(2): 190-191. doi: 復(fù)制
| 1. | Barnett M.Management of end-stage chronic obstructive pulmonary disease. Br J Nurs, 2008, 17: 1390-1394. |
| 2. | Sadeghnejad A, Meyers DA, Bottai M, et al. IL-13 promoter polymorphism 1112C/ T modulates the adverse effect of tobacco smoking on lung function. AmJ Respir Crit Care Med, 2007,176:748-752. |
| 3. | Rubin P, Mollison KW. Pharmacotherapy of diseases mediated by 5 -lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat, 2007, 83: 188-197. |
| 4. | Zheng T, Zhu Z, Wang Z, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest, 2000, 106: 1081-1093. |
| 5. | Hacievliyagil SS, Gunen H, Mutlu LC, et al. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med, 2006, 100: 846-854. |
| 6. | Bowles KS, Beadle RE, Mouch S, et al. A novel model of equine recurrent airway obstruction. Vet Immunol Immunopathol, 2002, 87:385-389. |
| 7. | Cohn L, Whittaker L, Niu N, et al. Cytokine regulation of mucus production in a model of allergic asthma. Novartis Found Symp,2002, 248: 201-213. |
| 8. | Tanino M, Betsuyaku T, Takeyabu K, et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible pulmonary emphysema. Thorax, 2002, 57: 405-411. |
| 9. | Beeh KM, Kornmann O, Buhl R, et al. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest, 2003, 123: 1240-1247. |
| 10. | Vargaftig BB, Singer M. Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lungs. Am J Physiol Lung Cell Mol Physiol, 2003, 284: L260-L269. |
| 11. | Vargaftig BB, Singer M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol, 2003, 28: 410-419. |
- 1. Barnett M.Management of end-stage chronic obstructive pulmonary disease. Br J Nurs, 2008, 17: 1390-1394.
- 2. Sadeghnejad A, Meyers DA, Bottai M, et al. IL-13 promoter polymorphism 1112C/ T modulates the adverse effect of tobacco smoking on lung function. AmJ Respir Crit Care Med, 2007,176:748-752.
- 3. Rubin P, Mollison KW. Pharmacotherapy of diseases mediated by 5 -lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat, 2007, 83: 188-197.
- 4. Zheng T, Zhu Z, Wang Z, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest, 2000, 106: 1081-1093.
- 5. Hacievliyagil SS, Gunen H, Mutlu LC, et al. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med, 2006, 100: 846-854.
- 6. Bowles KS, Beadle RE, Mouch S, et al. A novel model of equine recurrent airway obstruction. Vet Immunol Immunopathol, 2002, 87:385-389.
- 7. Cohn L, Whittaker L, Niu N, et al. Cytokine regulation of mucus production in a model of allergic asthma. Novartis Found Symp,2002, 248: 201-213.
- 8. Tanino M, Betsuyaku T, Takeyabu K, et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible pulmonary emphysema. Thorax, 2002, 57: 405-411.
- 9. Beeh KM, Kornmann O, Buhl R, et al. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest, 2003, 123: 1240-1247.
- 10. Vargaftig BB, Singer M. Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lungs. Am J Physiol Lung Cell Mol Physiol, 2003, 284: L260-L269.
- 11. Vargaftig BB, Singer M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol, 2003, 28: 410-419.